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Abstract The cattle ticks, Rhipicephalus (Boophilus) spp.,
affect cattle production in tropical and subtropical regions
of the world. Tick vaccines constitute a cost-effective and
environmentally friendly alternative to tick control. The
recombinant Rhipicephalus microplus Bm86 antigen has
been shown to protect cattle against tick infestations.
However, variable efficacy of Bm86-based vaccines against
geographic tick strains has encouraged the research for
additional tick-protective antigens. Herein, we describe the
analysis of R. microplus glutathione-S transferase, ubiquitin
(UBQ), selenoprotein W, elongation factor-1 alpha, and
subolesin (SUB) complementary DNAs (cDNAs) by RNA
interference (RNAi) in R. microplus and Rhipicephalus
annulatus. Candidate protective antigens were selected for
vaccination experiments based on the effect of gene
knockdown on tick mortality, feeding, and fertility. Two
cDNA clones encoding for UBQ and SUB were used for
cattle vaccination and infestation with R. microplus and
R. annulatus. Control groups were immunized with
recombinant Bm86 or adjuvant/saline. The highest vaccine
efficacy for the control of tick infestations was obtained for
Bm86. Although with low immunogenic response, the
results with the SUB vaccine encourage further investiga-
tions on the use of recombinant subolesin alone or in
combination with other antigens for the control of cattle
tick infestations. The UBQ peptide showed low immuno-
genicity, and the results of the vaccination trial were
inconclusive to assess the protective efficacy of this
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antigen. These experiments showed that RNAi could be
used for the selection of candidate tick-protective antigens.
However, vaccination trials are necessary to evaluate the
effect of recombinant antigens in the control of tick
infestations, a process that requires efficient recombinant
protein production and formulation systems.
Introduction
Rhipicephalus (Boophilus) spp. ticks are distributed in
tropical and subtropical regions of the world with range
expansion for some species due to changes in climatic
conditions (Barker and Murrell 2004; Estrada-Peña et al.
2006; Olwoch et al. 2007). Infestations with the cattle tick,
Rhipicephalus microplus, economically impact cattle pro-
duction by reducing weight gain and milk production, and
by transmitting pathogens that cause babesiosis (Babesia
bovis and Babesia bigemina) and anaplasmosis (Anaplasma
marginale; Peter et al. 2005). Rhipicephalus annulatus is
present in regions of Asia, Latin America, and Africa
(Estrada-Peña et al. 2006) where it may also affect cattle
production and transmit pathogens.
Acaricide application constitutes a major component of
integrated tick control strategies (Graf et al. 2004).
However, use of acaricides has had limited efficacy in
reducing tick infestations and is often accompanied by
serious drawbacks, including the selection of acaricide-
resistant ticks, environmental contamination, and contami-
nation of milk and meat products with drug residues (Graf
et al. 2004). All of these issues reinforce the need for
alternative approaches to control tick infestations such as
the use of hosts with natural resistance to ticks, pheromone-
impregnated decoys for attracting and killing ticks, biolog-
ical control agents, and vaccines (de la Fuente and Kocan
2006; Sonenshine et al. 2006; Willadsen 2006).
In the early 1990s, vaccines inducing immunological
protection on vertebrate hosts against tick infestations were
developed and commercialized. The commercial vaccines,
Gavac and TickGARD, contained the recombinant
R. microplus Bm86 gut antigen (Willadsen et al. 1989;
Rand et al. 1989; Rodríguez et al. 1994; de la Fuente and
Kocan 2003; de la Fuente et al. 2007a). These vaccines
reduce the number of engorging female ticks, their weight,
and reproductive capacity. Thus, the greatest vaccine effect
was the reduction of larval infestations in subsequent
generations. Vaccine-controlled field trials in combination
with acaricide treatments demonstrated that an integrated
approach resulted in control of tick infestations while
reducing the use of acaricides (de la Fuente et al. 1998,
2007a; de la Fuente and Kocan 2003). These trials
demonstrated that control of ticks by vaccination has the
advantages of being cost-effective, reducing environmental
contamination, and preventing the selection of drug
resistant ticks that result from repeated acaricide applica-
tion. In addition, these vaccines may also prevent or reduce
transmission of pathogens by reducing tick populations
and/or affecting tick vector capacity (de la Fuente et al.
1998, 2007a; Rodríguez Valle et al. 2004).
Controlled immunization trials have shown that R. microplus
Bm86-containing vaccines also protect against related tick
species, R. annulatus and Rhipicephalus decoloratus
(Fragoso et al. 1998; de la Fuente et al. 2000a; de Vos et
al. 2001). However, R. microplus strain-to-strain variations
in the susceptibility to Bm86 vaccination have been
reported, and the efficacy of the Bm86 vaccine is higher
against R. annulatus than against R. microplus strains,
suggesting that tick genetic and/or physiological differ-
ences may affect the efficacy of tick vaccines in different
regions (Fragoso et al. 1998; García-García et al. 1999;
2000; de la Fuente et al. 1999, 2000a, b; de Vos et al.
2001; de la Fuente and Kocan 2006; Sossai et al. 2005;
Canales et al. 2009a). These results together with the need
to improve vaccine efficacy have encouraged research for
additional tick protective antigens for the control of cattle
tick infestations (de la Fuente and Kocan 2003, 2006;
Sonenshine et al. 2006; Willadsen 2006).
In the experiments reported herein, selected R. microplus
complementary DNA (cDNA) sequences were character-
ized by RNA interference (RNAi) in unfed and replete adult
ticks. Tick subolesin and ubiquitin were used for vaccina-
tion trials with recombinant proteins in cattle to evaluate
their capacity to protect against cattle tick infestations.
Materials and methods
Tick strains The R. microplus (susceptible Media Joya
strain, CENAPA, Mexico) and R. annulatus (Mercedes
strain, Texas, USA) ticks were obtained from laboratory
colonies maintained at the University of Tamaulipas,
Mexico. Originally, these tick strains were collected from
infested cattle in Tapalpa, Jalisco, Mexico and Mercedes
County, Texas, USA for R. microplus and R. annulatus,
respectively. Tick larvae were fed on cattle and collected
after repletion to allow for oviposition and hatching in
humidity chambers at 12 h light:12 h dark photoperiod, 22–
25°C, and 95% relative humidity (RH). Larvae were
15 days old at the time of infestations.
RNA interference in ticks Genes for RNAi were selected
based on previous results in R. microplus or Dermacentor
variabilis demonstrating the effect of gene knockdown on
tick attachment, mortality, and/or fertility (de la Fuente et
al. 2007b; 2008). These genes included those encoding for
putative glutathione-S transferase (GST; GenBank acces-
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sion number AF077609), ubiquitin (UBQ; AA257892),
selenoprotein W (SEL; tentative consensus sequence
TC19044, http://compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/
tc_report.pl?gudb=b_microplus&tc=TC19044), elongation
factor-1 alpha (EF-1a; EU436163), and subolesin (SUB;
DQ159966).
Oligonucleotide primers containing T7 promoter se-
quences at the 5′-end (GST: GSTBMT75: 5′- TAATACG
ACTCACTATAGGGTACTCCATGGCTCCTGTGCTC
GGCT-3′ and GSTBMT73: 5′- TAATACGACTCACTATA
GGGTACTCATTGAGAGGCCACTTAATGC-3′; UBQ:
UB2BMT75: 5 ′-TAATACGACTCACTATAGGGTACT
TTGGTCCTGCGGCTCCGCGGAG-3′ and UB2BMT73:
5′-TAATACGACTCACTATAGGGTACTGCCACCACGG
AGCCGCAGGACA-3′; SEL: SEBMT75: 5’-TAATAC
GACTCACTATAGGGTACTCCACCGTGACTGGCACAG
TAG-3′ and SEBMT73: 5′-TAATACGACTCACTATAGGG
TACTCCATACATGAATGGCTTTCCA-3′; EF-1a: GII5:
5´-TAATACGACTCACTATAGGGTACTGGCCCACGGAC
AAACCCCTC-3′ and GII3: 5′-TAATACGACTCACTATAG
GGTACTCGACCGTTTGCCTCATGTC-3 ′ ; SUB:
D8BMT75: 5′-TAATACGACTCACTATAGGGTACTGACT
GGGACCCCTTGCACAGT-3′ and D8BMT73 5′-TAATAC
GACTCACTATAGGGTACTCGAGTTTGGTAGATAG
CACA-3) were synthesized and used for in vitro transcrip-
tion of double-stranded RNA (dsRNA) using the Access
reverse transcription–polymerase chain reaction (RT–PCR)
system (Promega, Madison, WI, USA) and the Megascript
RNAi kit (Ambion, Austin, TX, USA) following manufac-
turer's instructions. The dsRNA was purified and quantified
by spectrophotometry.
Newly molted R. microplus and R. annulatus females
were injected with approximately 0.3 µl of dsRNA (5×1010
molecules per microliter) in the lower right quadrant of the
ventral surface of the exoskeleton of the tick (Nijhof et al.
2007). Thirty ticks per group were injected using a
Hamilton syringe with a 1-inch, 33-gauge needle. Control
ticks were injected with the unrelated GIII dsRNA or were
left uninjected. The GIII sequence was identified in
R. microplus and did not affect tick feeding, mortality,
and oviposition after RNAi (unpublished results). Ticks
were held in a humidity chamber for 3–5 h before surviving
ticks were allowed to feed in separate patches, each one for
a different group, glued on the back of a calf. Ten males
were placed in each patch simultaneously with injected
females. Unattached ticks were removed 2 days after
infestation, and attached ticks were allowed to feed until
repletion. Engorged female ticks started to drop off the host
after 8 days and were collected during 4 days. All the
females completing feeding were counted and weighted.
The average ± standard deviation (SD) weights of engorged
females were compared between test and control groups by
Student's t test (P=0.05). Tick attachment was recorded
with respect to surviving ticks after injection, and tick
mortality was recorded with respect to the total number of
attached ticks feeding on the animal and were compared
between test and control groups by χ2 test (α=0.01). For
oviposition, individual ticks were held in a humidity
chamber at 22–25°C and 95% RH, and the egg mass
oviposited by each tick was weighted and compared between
test and control groups by Student's t test (P=0.05).
Engorged R. microplus and R. annulatus females were
weighted and injected with 5 µl of dsRNA (5×1010
molecules per microliter) in the right spiracular plate within
6 h after dropping off the host using the same methods as
described above or left uninjected. They were stored
individually in an incubator at 22–25°C and 80% RH. Tick
weight and egg masses removed after oviposition and
weighted were analyzed as described above. Egg batches
were stored separately under the same conditions to
estimate percent hatching by counting the number un-
hatched eggs that was compared between test and control
groups by χ2 test (α=0.01).
Ten ticks per group were dissected after oviposition and
pooled for RNA extraction to evaluate gene expression by
semiquantitative RT–PCR using the same oligonucleotide
primers used for dsRNA synthesis. The messenger RNA
(mRNA) levels (nanograms per amplicon) were estimated
in ethidium bromide-stained agarose gels by comparison to
a standard curve of the target gene and compared between
target gene dsRNA and GIII dsRNA-injected control ticks
to calculate the percent of gene silencing after RNAi.
Vaccine formulations R. microplus UBQ and SUB were
produced for vaccination trials. Recombinant SUB was
expressed in Escherichia coli from a synthetic gene
(GenBank accession number GQ456170) optimized for
codon usage in E. coli and purified by Ni affinity
chromatography (Genscript Corporation, Piscatway, NJ,
USA; www.genscript.com). The UBQ peptide NH2-
YNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEV
EPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLED was
synthesized and purified at the Bioanalytics, Pharmacology,
and Proteomics facility (Barcelona Biomedical Research
Park, Spain). The recombinant Bm86 (susceptible strain)
used as positive control was secreted in Pichia pastoris and
purified as reported previously (Canales et al. 2008).
Protein adjuvation was made by mixing a solution of
anhydromannitoletheroctodecenoate (Montanide ISA 50 V;
Seppic, Paris, France) with the recombinant protein
solution in batch-by-batch processes using a high-speed
mixer Heidolph DIAX 900 (Heidolph Elektro, Kelheim,
Germany) at 8,000 rpm, and the vaccine was filled
manually under sterile conditions in glass bottles of 20 ml
(Wheaton, Millville, NJ, USA) at a concentration of
100 µg/2 ml dose. Quality controls were made by testing
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mechanical and thermal stability of vaccine emulsions as
described previously (Canales et al. 1997).
Cattle immunization with recombinant proteins and tick
infestations Four 1-year-old European crossbred calves per
group were each immunized with three doses (weeks 1, 4,
and 6) containing 100 µg per dose of purified recombinant
proteins formulated as described above. Negative controls
were injected with adjuvant/saline alone. Cattle were
injected intramuscularly with 2 ml/dose using a 5-ml
syringe and an 18-gauge needle. Two weeks after the last
immunization, cattle in vaccinated and control groups were
infested with 10,000 R. annulatus (Mercedes, Texas, USA
strain) and R. microplus (susceptible, Mexico strain) larvae/
animal applied individually to each animal in separate
cotton cells attached to the back of the animals. Cattle were
cared for in accordance with standards specified in the
Guide for Care and Use of Laboratory Animals.
Data collection and evaluation Adult engorged female
ticks dropping from cattle were daily collected, counted,
and weighted. All the collected adult female ticks were
assessed for oviposition and egg fertility (de la Fuente et al.
1999). The personnel collecting the ticks were “blinded” as
to which group animals belonged. The efficacy of vaccine
formulations was evaluated employing the following
formulae (de la Fuente et al. 1999; Canales et al. 2009a).
Effect on the number of adult female ticks DTð Þ ¼
100 l NTV=NTCð Þ½ , where NTV is the number of adult
female ticks in the vaccinated group, and NTC is the
number of adult female ticks in the control group.
Effect on tick weight DWð Þ ¼ 100 1 WTV=WTCð Þ½ ,
where WTV is the average adult female tick weight in the
vaccinated group, and WTC is the average adult female tick
weight in the control group.
Effect on oviposition DOð Þ ¼ 100 1 PATV=PATCð Þ½ ,
where PATV is the average weight of the eggs per survived
tick in the vaccinated group, and PATC is the average
weight of the eggs per survived tick in the control group.
Effect on egg fertility DFð Þ ¼ 100 1 PPLOV=ð½
PPLOCÞ, where PPLOV is the average weight of the
larvae per gram of eggs in the vaccinated group, and
PPLOC is the average weight of the larvae per gram of eggs
in the control group.
Vaccine efficacy (E) was calculated as 100 l CRTð½
CR0 CRFÞ, where CRT=NTV/NTC, CR0=PATV/
PATC, and CRF=PPLOV/PPLOC that represent the reduc-
tion in the number of adult female ticks, oviposition, and
egg fertility as compared to the control group, respectively.
A Student's t test with unequal variance (P=0.05) was
used to compare the results of adult female tick number,
tick weight, oviposition, and egg fertility between vaccinated
and control groups.
Determination of serum antibody levels by enzyme-linked
immunosorbent assay Before each immunization and
21 days after the last immunization, blood samples were
collected from each calf into sterile tubes and maintained at
4°C until arrival at the laboratory. Serum was then
separated after centrifugation and stored at −20°C. Serum
antibody titers were determined using an antigen-specific
indirect enzyme-linked immunosorbent assay (ELISA).
Purified UBQ, SUB, and Bm86 (susceptible strain)
antigens (0.1 µg per well) were used to coat ELISA plates
overnight at 4°C. Sera were serially diluted to 1:10, 1:100,
and 1:1,000 in phosphate-buffered saline with Tween 20
(PBST; PBS/0.5% Tween 20, pH 7.2) and 10% fetal bovine
serum (Sigma). The plates were incubated with the diluted
sera for 1 h at 37°C and then incubated with 1:10,000 rabbit
antibovine immunoglubolinG (IgG)–horseradish peroxidase
conjugates (Sigma) for 1 h at 37°C. The color reaction was
developed with 3,3′,5,5′- tetramethylbenzidine (Sigma), and
the optical density450 nm (OD) was determined. After
incubation, the plates were washed with PBST. Antibody
titers were considered positive when they yielded an
OD450 nm value at least twice as high as the preimmune
serum. Antibody titers in immunized cattle were expressed
as the OD450 nm value for the highest serum dilution
(1:1,000) and compared between vaccinated and control
cattle using an analysis of variance (ANOVA) test (P<
0.05). Correlation analyses were conducted in Microsoft
Excel to compare antibody titers at the time of tick
infestation and vaccine efficacy calculated in individual
cattle.
Results and discussion
The discovery and characterization of new tick-protective
antigens is important to improve existing vaccines for the
control of cattle tick infestations (de la Fuente et al. 2007a).
However, the expenses and difficulties associated with the
screening of tick-protective antigens and cattle vaccination
trials constitute an obstacle toward this goal. Recently, RNAi
has been proposed as a method for the rapid screening of
tick-protective antigens (de la Fuente et al. 2005, 2007c).
However, vaccination trials are ultimately needed to charac-
terize new candidate tick-protective antigens.
In these experiments, RNAi was used to select the
antigens for vaccination trials based on the effect of gene
knockdown on cattle tick mortality, feeding, and fertility.
The GST, UBQ, SEL, EF-1a, and SUB genes were selected
for RNAi experiments in R. annulatus and/or R. microplus
based on previous results in R. microplus or D. variabilis
demonstrating an effect of gene knockdown on tick
attachment, mortality, and/or fertility (de la Fuente et al.
2007b, 2008). The results showed that GST and SEL gene
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knockdown affected tick attachment (60% and 65% tick
attachment, respectively, when compared to 91% attach-
ment in the controls; α<0.01) as in previous experiments
with D. variabilis (de la Fuente et al. 2007b) but had no
effect on R. microplus mortality and oviposition (Table 1)
and were not characterized further. As in previous experi-
ments (de la Fuente et al. 2007b, 2008), RNAi with UBQ,
EF-1a, and SUB increased R. microplus mortality and
reduced oviposition when compared to controls (Table 1).
Despite the fact that gene expression was silenced between
75% and 100% in target gene dsRNA-injected R. microplus
and R. annulatus ticks when compared to controls, in
R. annulatus, only EF-1a knockdown had an effect on both
tick mortality and oviposition (Table 2). However, tick-to-
tick variations in RNAi results were higher in R. annulatus
than in R. microplus probably because RNAi conditions are
better established for R. microplus (Nijhof et al. 2007).
R. microplus UBQ, SUB, and EF-1a were selected for
vaccination trials based on their effect on tick mortality and/
or oviposition after RNAi (Tables 1 and 2). However,
recombinant EF-1a could not be produced in sufficient
quantities for protein purification and vaccination trials
were conducted with recombinant UBQ and SUB only in
comparison with Bm86 (positive control) and adjuvant/
saline (negative control).
Except for cattle immunized with recombinant SUB,
antibody titers in vaccinated cattle increased after succes-
sive immunizations (Fig. 1). However, anti-UBQ antibody
titers in immunized cattle were not significantly different
from control animals (Fig. 1). The poor immunogenicity of
the UBQ vaccine could reflect self-tolerance to a highly
conserved molecule in eukaryotes and the fact that short
peptides are often not immunogenic and require conjuga-
tion to a carrier protein or the use of potent adjuvants to
Table 1 Summary of RNAi experiments in unfed and engorged R. microplus female ticks
Parameter R. microplus cDNA group
GST UBQ SEL SUB EF-1a GIII UNI
Unfed female R. microplus
Tick mortality (%) 43 77* 50 73* 77* 53 27
ND 70* 53 67* 73* 53 ND
Tick weight (mg) 214±115** 85±129*** 211±124** 8±2*** 55±140*** 307±125 485±113
ND 227±95 191±130** 7±3*** 4±5*** 292±125 ND
Eggs/tick (mg) 80±60 0±0*** 59±64 8±2** 22±58 26±39 103±64
ND 0±0*** 121±43 0±0*** 0±0*** 61±51 ND
Engorged female R. microplus
Tick weight (mg) 301±67 314±18 302±47 284±45 324±39 364±22 288±72
Eggs/tick (mg) 151±34 89±30*** 109±14** 101±83 123±89 191±10 158±46
Egg hatching (%) 70 30* 30* 10* 5* 70 80
Adult ticks (N=30 for unfed and N=3 for engorged females) were injected with dsRNA or left uninjected (UNI). Two experiments were
conducted in unfed ticks while a single experiment was done with engorged female ticks. Tick mortality and egg hatching are shown in percent
and were compared to the GIII dsRNA-injected control ticks by χ2 test (*α<0.01). Tick weight and oviposition (eggs per tick) are shown as
average ± SD and were compared to the GIII dsRNA-injected control ticks by Student's t test (**P<0.05; ***P<0.01)
ND not done, UNI uninjected
Table 2 Summary of RNAi experiments in unfed R. annulatus female ticks
Parameter R. microplus cDNA group
UBQ SUB EF-1a GIII UNI
Tick mortality (%) 63* 47 90* 47 53
Tick weigh (mg) 235±113 69±86*** 25±22*** 206±108 199±128
Eggs/tick (mg) 97±70 70±83 0±0*** 114±56 116±71
Hatching (%) 80 20* 0* 100 90
Adult unfed female ticks (N=30) were injected with dsRNA or left uninjected (UNI). Tick mortality and egg hatching are shown in percent and
were compared to the GIII dsRNA-injected control ticks by χ2 test (*α<0.01). Tick weight and oviposition (eggs per tick) are shown as average ±
SD and were compared to the GIII dsRNA-injected control ticks by Student's t test (**P<0.05; ***P<0.01)
UNI uninjected
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increase immunogenicity (Rodríguez et al. 1994; Haro and
Gómara 2004). In cattle immunized with recombinant SUB,
antibody titers increased after the first immunization and
then decreased after the second immunization (Fig. 1). The
cause for this decrease in anti-SUB antibody titers after the
second immunization is unknown but could be due to
problems associated with the stability of the vaccine
formulation. The vaccine containing the recombinant
Bm86 antigen in Montanide ISA 50 V has been shown to
be stable even at field temperature (Canales et al. 2007 and
unpublished results), but vaccine stability could be different
for different antigen preparations. In general, antibody titers
were low in immunized cattle, even in the animals
vaccinated with the control Bm86 vaccine when compared
to previous studies (Canales et al. 2009a). Although cattle
were apparently healthy, low antibody responses after
vaccination suggested that animals were probably not in
the best health condition. Nevertheless, a positive correla-
tion (correlation coefficients R2=0.7, 0.8, and 0.9 in UBQ-,
SUB-, and Bm86-immunized cattle, respectively) between
antibody titers 1 week after tick infestation and vaccine
efficacy calculated in individual cattle was obtained for
R. microplus. For R. annulatus, a positive correlation (R2=
0.6) between antibody titers and vaccine efficacy was
obtained in SUB-immunized cattle only. A positive corre-
lation between antibody titers and vaccine efficacy has been
previously demonstrated in Bm86-vaccinated cattle and
underlines the effect of antitick vaccines on the control of
cattle tick infestations (Cobon et al. 1995; de la Fuente
et al. 1998).
The results of the vaccine trial showed an effect on
R. microplus and R. annulatus infestations for all three
antigens when compared to controls (Tables 3 and 4). The
efficacy with the Bm86 vaccine were within the range
reported in previous experiments (Cobon et al. 1995;
Fragoso et al. 1998; de la Fuente et al. 1998, 1999,
2000a, b; García-García et al. 2000; de Vos et al. 2001; de
la Fuente and Kocan 2003, 2006; Canales et al. 2009a) and
was higher than that obtained with UBQ and SUB vaccines
Tick infestation
Fig. 1 Antibody response in vaccinated cattle. Bovine serum
antibody titers to recombinant antigens were determined by ELISA
in cattle vaccinated with ubiquitin, subolesin, Bm86, and adjuvant/
saline control. Antibody titers in immunized cattle were expressed as
the OD450 nm value for the highest serum dilution (1:1,000) and
compared between vaccinated and control cattle using an ANOVA test
(*P<0.05). The time of vaccination shots (arrows) and tick infestation
are indicated
Table 3 Control of R. microplus infestations in cattle vaccinated with the recombinant antigens
R. microplus (susceptible; Mexico strain)
Percent reduction (vaccinated/control)b Ec
Experimental groupa DT DW DO DF
Ubiquitin 26% 9% –2% 29% 55%
(1,079±410) (251±52) (109±9) (0.37±0.04)
Subolesin 43% 0% 0% 15% 51%
(835±179)* (277±33) (107±21) (0.44±0.06)
Bm86 51% 5% 14% 6% 60%
(714±208)* (261±26) (92±16) (0.49±0.04)
Adjuvant/saline control (1,454±206) (276±14) (107±12) (0.52±0.29) –
DT percentage reduction in tick infestation, DW percentage reduction in tick weight, DO percentage reduction in oviposition, DF percentage
reduction in egg fertility
a Cattle were randomly assigned to experimental groups (N=4), vaccinated, and challenged with R. microplus and R. annulatus larvae
b The percent reduction was calculated with respect to the control group. In parenthesis are shown the average ± SD for adult female tick number,
tick weight (milligram), oviposition (egg weight (milligram) per tick), and egg fertility (larvae weight per egg weight) and were compared by
Student's t test with unequal variance between vaccinated and control groups (*P<0.05)
c Vaccine efficacy (E) was calculated as 100 l CRT CR0 CRFð Þ½ , where CRT, CRO, and CRF are the reduction in the number of adult
female ticks, oviposition, and egg fertility as compared to the control group, respectively
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in both tick species. Particularly for R. annulatus control, it
is difficult to improve the results obtained with Bm86
vaccines which attain >99% efficacy in all experiments
(Fragoso et al. 1998; de la Fuente et al. 2000a, b; de Vos et
al. 2001; Canales et al. 2009a). For SUB, this is the first
vaccination trial in R. microplus and R. annulatus, and the
results were similar to those reported in other tick species
(Almazán et al. 2005a, b; de la Fuente et al. 2006; Canales
et al. 2009b) and support further experiments with this
antigen. Vaccination with the UBQ peptide had some
efficacy on tick control, particularly on R. microplus
infestations (Table 3). However, these results were affected
by the low immunogenicity of the UBQ vaccine preparation
and require additional trials with improved peptide for-
mulations before a conclusion could be reached.
The genes were selected for vaccination trials based on
their effect on tick mortality and fertility after RNAi
experiments included those encoding for proteins involved
in the regulation of mRNA and protein synthesis and
metabolism with potential impact on important biological
processes in eukaryotes such as cell growth and mainte-
nance. However, these proteins are cytoplasmic and may be
evolutionary highly conserved which may pose a problem
for their use in vaccine formulations for the control of tick
infestations. As previously discussed, the conservation of
protein ortholog sequences among arthropod vectors and
vertebrate hosts may raise the question of safety when using
them for immunization with the potential of inducing
autoimmune responses damaging to the host (Canales et
al. 2009b). However, it is expected that the antibody
response would be primarily directed against nonself
epitopes thus reducing the possibility of detrimental effects
to the host. Additionally, immunization with intracellular
proteins has been effective in ticks and other invertebrate
organisms and suggests a low risk to induce autoimmune
responses in vertebrate hosts (Elad and Segal 1995;
Almazán et al. 2005a, b; de la Fuente et al. 2006; Canales
et al. 2009b).
In summary, these experiments showed that RNAi could
be used for the selection of candidate tick-protective
antigens. However, vaccination trials are necessary to
evaluate the effect of recombinant antigens in the control
of tick infestations, a process that requires efficient
recombinant protein production and formulation systems.
The results with the SUB vaccine encourage further
investigations on the use of recombinant subolesin alone
or in combination with other antigens for the control of
cattle tick infestations.
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Table 4 Control of R. annulatus infestations in cattle vaccinated with the recombinant antigens
R. annulatus (Mission, TX strain)
Percent reduction (vaccinated/control)b Ec
Experimental groupa DT DW DO DF
Ubiquitin −2% −19% −21% 15% 15%
(519±96) (275±29) (109±15) (0.13±0.03)
Subolesin 18% 17% 23% 37% 60%
(419±288) (192±129) (69±49) (0.09±0.07)
Bm86 100% All ticks All ticks All ticks 100%
(0±0)* Died Died Died
Adjuvant/saline control (509±145) (231±28) (90±20) (0.15±0.03) –
DT percentage reduction in tick infestation, DW percentage reduction in tick weight, DO percentage reduction in oviposition, DF percentage
reduction in egg fertility
a Cattle were randomly assigned to experimental groups (N=4), vaccinated, and challenged with R. microplus and R. annulatus larvae
b The percent reduction was calculated with respect to the control group. In parenthesis are shown the average ± SD for adult female tick number,
tick weight (milligram), oviposition (egg weight (milligram) per tick) and egg fertility (larvae weight per egg weight) and were compared by
Student's t test with unequal variance between vaccinated and control groups (*P<0.05)
c Vaccine efficacy (E) was calculated as 100 l CRT CR0 CRFð Þ½ , where CRT, CRO, and CRF are the reduction in the number of adult
female ticks, oviposition, and egg fertility as compared to the control group, respectively
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